Authors: William W. Busse, MD CME / ABIM MOC Released: 1/31/2020 Valid for credit through: 1/31/2021 START ACTIVITY Credits Available Physicians – maximum of 0.25 AMA PRA Category 1 Credit(s)™ ABIM Diplomates – maximum of 0.25 ABIM…
Authors: Nicola A. Hanania, MD CME / ABIM MOC Released: 1/31/2020 Valid for credit through: 1/31/2021 START ACTIVITY Target Audience and Goal Statement This activity is intended for pulmonologists, allergists & clinical immunologists,…
Case report – Open Access David Clofent, Miquel de Homdedeu, Mariana Muñoz-Esquerre, María Jesús Cruz & Xavier Muñoz Allergy, Asthma & Clinical Immunology volume 16, Article number: 7 (2020) Abstract Background Sudan red or 1-[(2-methoxyphenyl)azo]-2-naphthol is a low molecular weight…
This activity is supported by an educational grant from Merck & Co., Inc.0.50 CME 0.50 ABIM MOC 30 MINS $0 FEE Overview Provider Statement This continuing medical education activity is…
Research – Open Access Michael J. McGeachie, Joanne E. Sordillo, Amber Dahlin, Alberta L. Wang, Sharon M. Lutz, Kelan G. Tantisira, Ronald Panganiban, Quan Lu, Satria Sajuthi, Cydney Urbanek, Rachel Kelly, Benjamin Saef, Celeste Eng, Sam S. Oh, Alvin T. Kho, Damien C. Croteau-Chonka, Scott T.…
Brandon May Thickened airway walls, which correlate with airway obstruction and/or occlusion, are greatly increased in patients with severe asthma, according to study results published in the American Journal of Respiratory…
Abstract Objective: To evaluate usability of mepolizumab as a liquid drug product self-administered via a single-use prefilled autoinjector (AI) by patients with severe eosinophilic asthma (SEA), or their caregivers, in-clinic and…
CME Authors: Ratko Djukanovic, MD, DM, FRCP (Chair), Stephen P. Peters, MD, PhD, FAAAAI, FACP, FCCP, FCPP, Michael E. Wechsler, MD, MMSc CME Released: 12/31/2019 Valid for credit through: 12/30/2020 START ACTIVITY Credits…
Steve Duffy The Food and Drug Administration has granted Fast Track designation to NanoFlu (Novavax) for seasonal influenza vaccination in adults ≥65 years. NanoFlu is a recombinant hemagglutinin (HA) protein…